adagrasib,Pembrolizumab
mirati,merck
[]
 pattern of liver toxicity is interesting although given sobering and severe visceral toxicity previously seen would exercise extreme caution, may appear late efficacy has been underwhelming with soto without any improvement in os thus far despite pfs
Medical Director LCC Cancer Center, Medical Director Cancer Genetics, Investigator Clinical Cancer Trials,IRB, Professor, Cancer Committee